Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No. )
| | | | | | | | | | | |
Filed by the Registrant | x | Filed by a Party other than the Registrant | o |
| | | | | |
Check the appropriate box: |
| |
o | Preliminary Proxy Statement |
| |
o | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| |
o | Definitive Proxy Statement |
| |
x | Definitive Additional Materials |
| |
o | Soliciting Material under §240.14a-12 |
| | |
Rapid Micro Biosystems, Inc. |
(Name of Registrant as Specified in its Charter) |
|
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) |
| | | | | |
Payment of Filing Fee (Check all boxes that apply): |
| |
x | No fee required. |
| |
o | Fee paid previously with preliminary materials. |
| |
o | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |